Lamivudine (Epivir), Abacavir (Ziagen), and Tenofovir (Viread): Early Virologic Non-Response with Concomitant Use
July 31, 2003
Once-daily treatment of therapy-naive HIV-1 infected adults with the combination of lamivudine (Epivir), abacavir (Ziagen), and tenofovir (Viread) resulted in early virologic non-response in a recent study. Avoid using this combination in treatment-naïve patients. Additional information is available at the following links:
- MedWatch Alert:
- Letter to Healthcare Professionals:
July 31, 2003; University of Utah, Drug Information Service. Copyright 2009, Drug Information Service, University of Utah, Salt Lake City, UT.